Lamb, L S <br/><br/>
Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease.  [electronic resource] 

 -  Cytometry  Oct 1999 
 - 238-43 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0196-4763 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0320(19991015)38:5<238::aid-cyto6>3.0.co;2-o  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers--analysis<br/>Bone Marrow Transplantation<br/>CD4 Lymphocyte Count<br/>CD4-Positive T-Lymphocytes--immunology<br/>Cell Separation<br/>Chronic Disease<br/>Flow Cytometry<br/>Graft vs Host Disease--immunology<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Lymphocyte Activation<br/>Lymphocyte Depletion--methods<br/>Methylprednisolone--therapeutic use<br/>Receptors, Immunologic--biosynthesis<br/>Receptors, OX40<br/>Receptors, Tumor Necrosis Factor<br/>Transplantation Conditioning<br/>Tumor Necrosis Factor Receptor Superfamily, Member 7--biosynthesis